Skip to content
Disclosery

EXANE DERIVATIVES: NCLH position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on NCLH, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 118 NCLH shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 118 shares
    Change vs previous 13F 0 shares

    <0.01% of the 13F portfolio, value $1,312.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 118 shares
    Change vs previous 13F -28 shares

    <0.01% of the 13F portfolio, value $2,582.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 146 shares
    Change vs previous 13F -894 shares

    <0.01% of the 13F portfolio, value $3,028.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 1,040 shares
    Change vs previous 13F -334 shares

    0.01% of the 13F portfolio, value $27,778.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 1,374 shares
    Change vs previous 13F -5,204 shares

    0.01% of the 13F portfolio, value $35,848.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 6,578 shares
    Change vs previous 13F -4,975 shares

    0.05% of the 13F portfolio, value $181,486.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 11,553 shares
    Change vs previous 13F +886 shares

    0.09% of the 13F portfolio, value $293,790.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 10,667 shares
    Change vs previous 13F not available

    0.06% of the 13F portfolio, value $182,508.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).